These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 7507156)

  • 21. Enhanced complement susceptibility of avidin-biotin-treated human erythrocytes is a consequence of neutralization of the complement regulators CD59 and decay accelerating factor.
    Zaltzman AB; Van den Berg CW; Muzykantov VR; Morgan BP
    Biochem J; 1995 May; 307 ( Pt 3)(Pt 3):651-6. PubMed ID: 7537958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and functional characterization of a new gene encoding the mouse terminal complement inhibitor CD59.
    Qian YM; Qin X; Miwa T; Sun X; Halperin JA; Song WC
    J Immunol; 2000 Sep; 165(5):2528-34. PubMed ID: 10946279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the complement regulatory protein CD59 on human spermatozoa: characterization and role in gametic interaction.
    Fenichel P; Cervoni F; Hofmann P; Deckert M; Emiliozzi C; Hsi BL; Rossi B
    Mol Reprod Dev; 1994 Jul; 38(3):338-46. PubMed ID: 7522480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors.
    Fishelson Z; Donin N; Zell S; Schultz S; Kirschfink M
    Mol Immunol; 2003 Sep; 40(2-4):109-23. PubMed ID: 12914817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alternative complement pathway-mediated myeloid cell cytotoxicity: repertoire of membrane factors participating in regulation of C3 deposition and cytolysis.
    Matsumoto M; Sugita Y; Seya T
    Eur J Immunol; 1991 Aug; 21(8):1787-92. PubMed ID: 1714391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis.
    Gorter A; Blok VT; Haasnoot WH; Ensink NG; Daha MR; Fleuren GJ
    Lab Invest; 1996 Jun; 74(6):1039-49. PubMed ID: 8667608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of transfected MACIF (CD59) on complement-mediated swine endothelial cell lysis, compared with those of membrane cofactor protein (CD46) and decay-accelerating factor (CD55).
    Miyagawa S; Shirakura R; Nakata S; Izutani H; Matsuda H; Iwata K; Nagasawa S; Terado A; Hatanaka M; Matsumoto M
    Transplant Proc; 1995 Feb; 27(1):328-9. PubMed ID: 7533401
    [No Abstract]   [Full Text] [Related]  

  • 28. Expression of CD59, a regulator of the membrane attack complex of complement, on human skeletal muscle fibers.
    Navenot JM; Villanova M; Lucas-Héron B; Malandrini A; Blanchard D; Louboutin JP
    Muscle Nerve; 1997 Jan; 20(1):92-6. PubMed ID: 8995588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human lung cancer cell lines express cell membrane complement inhibitory proteins and are extremely resistant to complement-mediated lysis; a comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistance.
    Varsano S; Rashkovsky L; Shapiro H; Ophir D; Mark-Bentankur T
    Clin Exp Immunol; 1998 Aug; 113(2):173-82. PubMed ID: 9717965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complement regulatory proteins in glomerular diseases.
    Nangaku M
    Kidney Int; 1998 Nov; 54(5):1419-28. PubMed ID: 9844117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein.
    Iwata K; Seya T; Ariga H; Nagasawa S
    J Immunol; 1994 Apr; 152(7):3436-44. PubMed ID: 7511647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human nasal epithelium adsorbs complement C3-related fragments and expresses cell membrane complement regulatory proteins.
    Varsano S; Frolkis I; Shapiro H; Ophir D
    Laryngoscope; 1996 May; 106(5 Pt 1):599-604. PubMed ID: 8628088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure of a soluble, glycosylated form of the human complement regulatory protein CD59.
    Fletcher CM; Harrison RA; Lachmann PJ; Neuhaus D
    Structure; 1994 Mar; 2(3):185-99. PubMed ID: 7520819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
    Rollins SA; Zhao J; Ninomiya H; Sims PJ
    J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. H19, a surface membrane molecule involved in T-cell activation, inhibits channel formation by human complement.
    Whitlow MB; Iida K; Stefanova I; Bernard A; Nussenzweig V
    Cell Immunol; 1990 Mar; 126(1):176-84. PubMed ID: 1689219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identity of the segment of human complement C8 recognized by complement regulatory protein CD59.
    Lockert DH; Kaufman KM; Chang CP; Hüsler T; Sodetz JM; Sims PJ
    J Biol Chem; 1995 Aug; 270(34):19723-8. PubMed ID: 7544344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant C345C and factor I modules of complement components C5 and C7 inhibit C7 incorporation into the complement membrane attack complex.
    Thai CT; Ogata RT
    J Immunol; 2005 May; 174(10):6227-32. PubMed ID: 15879120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complement regulatory molecules on human myelin and glial cells: differential expression affects the deposition of activated complement proteins.
    Koski CL; Estep AE; Sawant-Mane S; Shin ML; Highbarger L; Hansch GM
    J Neurochem; 1996 Jan; 66(1):303-12. PubMed ID: 8522968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement inhibitors targeted to the proximal tubule prevent injury in experimental nephrotic syndrome and demonstrate a key role for C5b-9.
    He C; Imai M; Song H; Quigg RJ; Tomlinson S
    J Immunol; 2005 May; 174(9):5750-7. PubMed ID: 15843577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Membrane attack complex (MAC)-mediated damage to spermatozoa: protection of the cells by the presence on their membranes of MAC inhibitory proteins.
    Rooney IA; Davies A; Morgan BP
    Immunology; 1992 Mar; 75(3):499-506. PubMed ID: 1374057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.